February 27, 2019
New Clinical Study Tests a Pharmacotherapy Selection System that Aims to Improve the Impact of Diabetes Treatment
University of Utah Health (U of U Health) and Hitachi today announced that U of U Health has begun a prospective clinical study of a pharmacotherapy selection system co-developed with Hitachi at 13 primary care clinic sites starting from February 2019. The system supports patients and providers in selecting Type 2 diabetes mellitus (T2DM, the most common form of diabetes) treatment options by showing side-by-side comparisons of predicted treatment effect, risks and side effects, as well as costs for multiple medication regimens. By facilitating patient-provider communication and shared-decision making support, the aim is to keep patients fully engaged and committed to their treatment plan.
Through this clinical evaluation, U of U Health and Hitachi will continue their joint research efforts with a goal of improving the health and well-being of patients living with diabetes.
